The proposed University of Alabama at Birmingham (UAB) Rheumatic Disease Research Core Center (RDCC) is uniquely positioned to enable application of innovative, scientifically rigorous approaches and state-of-the-art techniques to important questions in biomedical sciences, thereby laying the basis for advances in the diagnosis and treatment of patients with arthritis and musculoskeletal diseases. The breadth of interdisciplinary research of the UAB Arthritis and Musculoskeletal Center, of which the RDCC is an essential element, provides a synergistic research environment that is focused through six RDCC thematic workgroups (Neurobehavioral Medicine; Prevention, Outcomes and Rehabilitation; Experimental Therapeutics; Genetics and Functional Genomics; Immunology and Autoimmunity; and Bone, Cartilage and Connective Tissue) These workgroups are designed to provide the depth of expertise necessary to fully exploit the rapid growth in scientific knowledge and advances in technology. Effective and rapid integration of these advances into the RDCC research efforts as well as effective communication between basic and clinical investigators will be further promoted by a Scientific Enrichment Program. The RDCC Core Facilities (Epitopes Recognition and Imunoreagent Core, Analytic and Preparative Flow Cytometry, Gene Targeting Facility, and High Resolution Imaging Facility) will provide and continue to develop the technologies essential for cutting edge research. Three innovative P&F projects, each of which uses innovative approaches to address important mechanistic questions in rheumatic diseases, are proposed that promote the development of investigators who are all new recruits to the study of rheumatic disease: (1) Primary Cilia and Bone Homeostasis; (2) Lipid regulation of Autoimmunity: Role of the LPC Effector, G2A; and (3) Functional Genomic Determinants of B Cell Homeostasis and Susceptibility to SLE. Continued scientific development, strategic planning, integration of efforts, and scientifically rigorous oversight are ensured through the expertise of the Administrative Core. ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR048311-07
Application #
7492218
Study Section
Special Emphasis Panel (ZAR1-KM-K (M1))
Program Officer
Mancini, Marie
Project Start
2001-09-28
Project End
2012-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
7
Fiscal Year
2008
Total Cost
$580,000
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Ladowski, Joseph M; Martens, Gregory R; Reyes, Luz M et al. (2018) Examining the Biosynthesis and Xenoantigenicity of Class II Swine Leukocyte Antigen Proteins. J Immunol 200:2957-2964
Hough, Kenneth P; Wilson, Landon S; Trevor, Jennifer L et al. (2018) Unique Lipid Signatures of Extracellular Vesicles from the Airways of Asthmatics. Sci Rep 8:10340
Chou, Chu-Fang; Hsieh, Yu-Hua; Grubbs, Clinton J et al. (2018) The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis. J Dermatol Sci 90:343-356
Friedman, Gregory K; Bernstock, Joshua D; Chen, Dongquan et al. (2018) Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression. Sci Rep 8:13930
Garner, Evan F; Williams, Adele P; Stafman, Laura L et al. (2018) FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts. Sci Rep 8:6913
Ladowski, Joseph M; Reyes, Luz M; Martens, Gregory R et al. (2018) Swine Leukocyte Antigen Class II Is a Xenoantigen. Transplantation 102:249-254
Harms, Ashley S; Thome, Aaron D; Yan, Zhaoqi et al. (2018) Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol 300:179-187
Lever, Jeremie M; Yang, Zhengqin; Boddu, Ravindra et al. (2018) Parabiosis reveals leukocyte dynamics in the kidney. Lab Invest 98:391-402
Chakraborty, Asmi; Dorsett, Kaitlyn A; Trummell, Hoa Q et al. (2018) ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage. J Biol Chem 293:984-994
Su, Hairui; Sun, Chiao-Wang; Liu, Szu-Mam et al. (2018) Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1. Blood Adv 2:2829-2836

Showing the most recent 10 out of 340 publications